Key result
Saphenous vein grafts develop significant disease in approximately 50% of patients within the first decade, prompting percutaneous interventions whose optimal stent type remains unclear.
Population
Patients with saphenous vein graft disease undergoing percutaneous coronary intervention
Design
Review
Authors
Loading...
Optimal stent choice in SVG PCI remains uncertain; leaves open dedicated RCTs on DES vs alternatives.
This review summarizes the current standard of care and ongoing controversies, such as the use of drug-eluting stents, in percutaneous interventions for saphenous vein graft disease.
Rodriguez et al. (2010) conducted a review in Saphenous vein graft disease. Percutaneous coronary intervention was evaluated. Saphenous vein grafts develop significant disease in approximately 50% of patients within the first decade, prompting percutaneous interventions whose optimal stent type remains unclear.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: